IGM Biosciences, Inc. 3 SEC Filings

Filed On	Filing
23 Apr 2024	Form 3: Harler Mary Beth, Head, Research & Autoimmunity Holds 86,797 shares of Common Stock
05 Oct 2023	Form 3: Thompson Elizabeth H.z., Director No securities owned
03 Jun 2022	Form 3: Weber Steven, Principal Accounting Officer
03 Aug 2021	Form 3: Takimoto Chris H, Chief Medical Officer No securities owned
26 Apr 2021	Form 3: Decker Lisa Lynn, Chief Business Officer
26 Apr 2021	Form 3: Gauthier George, Chief Commercial Officer Holds 200 shares of Common Stock
17 Sep 2019	Form 3: Topsoe Jakob Haldor, Director
17 Sep 2019	Form 3: Topsoe Christina Teng, Director
17 Sep 2019	Form 3: Tahir Misbah, Chief Financial Officer
17 Sep 2019	Form 3: Strohl William, Director
17 Sep 2019	Form 3: Schwarzer Fred, Director Holds 196,718 shares of Common Stock
17 Sep 2019	Form 3: Loberg Michael D, Director Holds 30,264 shares of Common Stock
17 Sep 2019	Form 3: Keyt Bruce, Chief Scientific Officer
17 Sep 2019	Form 3: Hambleton Julie, Director
17 Sep 2019	Form 3: Haldor Topsoe Holding A/S, 10% owner
17 Sep 2019	Form 3: Chen Daniel ShinYu, Chief Medical Officer Holds 116,518 shares of Common Stock
17 Sep 2019	Form 3: Behrens M Kathleen, Director
17 Sep 2019	Form 3: Redmile Group, Llc, Director and 1 other
17 Sep 2019	Form 3: Lee Michael Stewart, Director No securities owned
17 Sep 2019	Form 3: Neu Kelvin, Director No securities owned

Comments